Managing adverse effects associated with poly (ADP-ribose) polymerase inhibitors in ovarian cancer: a synthesis of clinical trial and real-world data

M Friedlander, YC Lee, WP Tew - American Society of Clinical …, 2023 - ascopubs.org
The use of poly (ADP-ribose) polymerase (PARP) inhibitor therapy is standard care in the
management of patients with various malignancies including ovarian, breast, prostate, and …

Interventions to improve spontaneous adverse drug reaction reporting by healthcare professionals and patients: systematic review and meta-analysis

V Paudyal, A Al-Hamid, M Bowen, MA Hadi… - Expert opinion on …, 2020 - Taylor & Francis
Introduction The aim of this study was to evaluate the effectiveness of interventions used for
improving ADR reporting by patients and healthcare professionals. Areas covered A …

Healthcare professionals' pharmacovigilance knowledge and adverse drug reaction reporting behavior and factors determining the reporting rates

MD Güner, PE Ekmekci - Journal of drug assessment, 2019 - Taylor & Francis
Background: Spontaneous adverse drug reaction (ADR) reports prepared by healthcare
professionals (HCPs) are the backbone of collecting post-marketing safety data. However …

A new paradigm in adverse drug reaction reporting: consolidating the evidence for an intervention to improve reporting

R Li, K Curtis, ST Zaidi, C Van… - Expert Opinion on Drug …, 2022 - Taylor & Francis
Introduction Adverse drug reaction (ADR) under-reporting is highly prevalent internationally
and interventions created to address this problem have only been temporarily successful …

Estimation of adverse drug reaction reporting in Iran: correction for underreporting

M Khalili, B Mesgarpour, H Sharifi… - … and drug safety, 2021 - Wiley Online Library
Abstract Propose Underreporting of Adverse Drug Reactions (ADRs) reduces the sensitivity
of pharmacovigilance systems. We described ADR reporting and its trend from 1999 to 2017 …

Situation analysis of the pharmacovigilance system in Nepal using the indicator-based pharmacovigilance assessment tool (IPAT)

N Jha, S Palaian, PR Shankar, S KC… - Journal of …, 2021 - academic.oup.com
Objectives The aim of this study was to assess the national and regional pharmacovigilance
centres in Nepal in terms of their policy frameworks, structure and functioning. Methods A …

Optimizing spontaneous adverse drug reaction reporting in public healthcare setting in Namibia

BA Adenuga, D Kibuule… - Basic & Clinical …, 2020 - Wiley Online Library
Despite the universal scale‐up of pharmacovigilance systems globally, adverse drug
reaction (ADR) reporting remains suboptimal among resource‐limited countries. Few …

Diagnosing malaria from some symptoms: a machine learning approach and public health implications

HI Okagbue, PE Oguntunde, ECM Obasi… - Health and …, 2021 - Springer
Malaria is a leading cause of death in Nigeria and remains a public health concern because
of the increasing resistance of the disease to antimalarial drugs. Pregnant women and …

[HTML][HTML] Terminologia especializada de enfermagem no cuidado às pessoas vivendo com aids

BCO Silva, RM Santos, FR Santos… - Acta Paulista de …, 2021 - SciELO Brasil
Objetivo: Construir e validar quanto ao conteúdo uma terminologia especializada de
Enfermagem, no cuidado a adultos vivendo com aids, fundamentado no Modelo de Sete …

[HTML][HTML] The effect of community dialogues and sensitization on patient reporting of adverse events in rural Uganda: Uncontrolled before-after study

HB Ndagije, L Manirakiza, D Kajungu, E Galiwango… - PloS one, 2019 - journals.plos.org
Background Patients experiencing adverse drug events (ADE) in many developing countries
are in the best position to report these events to the authorities but need to be empowered to …